Cardiol Therapeutics

CRDLNASDAQ
$1.91
-0.07-3.54%
Pre-Market: Jul 3, 4:22 PM EDT
15 minutes delayed
Cardiol Therapeutics (CRDL) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$3.00
Consensus Price Target1
$7.50

want to know what
the Bulls & Bears Say?

Cardiol Therapeutics (NASDAQ:CRDL) Stock, Analyst Ratings, Price Targets, Forecasts

Cardiol Therapeutics Inc has a consensus price target of $7.5 based on the ratings of 10 analysis. The 3 most-recent analyst ratings were released by Roth MKM, HC Wainwright & Co., and HC Wainwright & Co. on June 26, 2024, June 14, 2024, and June 7, 2024, respectively. With an average price target of $9.33 between Roth MKM, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 388.66% upside for Cardiol Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Roth MKM
HC Wainwright & Co.
Canaccord Genuity
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Cardiol Therapeutics

Buy NowGet Alert
06/26/2024Buy Now423.56%Roth MKM
Jason Wittes
 → $10Initiates → BuyGet Alert
06/14/2024Buy Now371.2%HC Wainwright & Co.
Vernon Bernardino
$9 → $9ReiteratesBuy → BuyGet Alert
06/07/2024Buy Now371.2%HC Wainwright & Co.
Vernon Bernardino
$9 → $9ReiteratesBuy → BuyGet Alert
05/23/2024Buy Now318.85%Canaccord Genuity
Edward Nash
$6 → $8MaintainsBuyGet Alert
05/14/2024Buy Now371.2%HC Wainwright & Co.
Vernon Bernardino
 → $9ReiteratesBuy → BuyGet Alert
04/22/2024Buy Now371.2%HC Wainwright & Co.
Vernon Bernardino
 → $9Initiates → BuyGet Alert
08/14/2023Buy Now57.07%Cantor Fitzgerald
Charles Duncan
 → $3ReiteratesOverweight → OverweightGet Alert
05/19/2023Buy Now214.14%Canaccord Genuity
Edward Nash
$5 → $6MaintainsBuyGet Alert
12/17/2021Buy Now318.85%Cantor Fitzgerald
Charles Duncan
—Initiates → OverweightGet Alert
12/03/2021Buy Now318.85%Canaccord Genuity
Edward Nash
—Initiates → BuyGet Alert

FAQ

Q

What is the target price for Cardiol Therapeutics (CRDL) stock?

A

The latest price target for Cardiol Therapeutics (NASDAQ:CRDL) was reported by Roth MKM on June 26, 2024. The analyst firm set a price target for $10.00 expecting CRDL to rise to within 12 months (a possible 423.56% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cardiol Therapeutics (CRDL)?

A

The latest analyst rating for Cardiol Therapeutics (NASDAQ:CRDL) was provided by Roth MKM, and Cardiol Therapeutics initiated their buy rating.

Q

When was the last upgrade for Cardiol Therapeutics (CRDL)?

A

There is no last upgrade for Cardiol Therapeutics

Q

When was the last downgrade for Cardiol Therapeutics (CRDL)?

A

There is no last downgrade for Cardiol Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Cardiol Therapeutics (CRDL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardiol Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardiol Therapeutics was filed on June 26, 2024 so you should expect the next rating to be made available sometime around June 26, 2025.

Q

Is the Analyst Rating Cardiol Therapeutics (CRDL) correct?

A

While ratings are subjective and will change, the latest Cardiol Therapeutics (CRDL) rating was a initiated with a price target of $0.00 to $10.00. The current price Cardiol Therapeutics (CRDL) is trading at is $1.91, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.